Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study
| dc.contributor.author | Heba M. Attash, Luma M. Al-Obaidy * and Harith Kh. Al-Qazaz | |
| dc.date.accessioned | 2026-09-22T10:25:45Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | 10.3390/vaccines10020186 | |
| dc.identifier.issn | 2076-393X | |
| dc.identifier.uri | https://drcentrallibrary.uomosul.edu.iq/handle/123456789/8754 | |
| dc.language.iso | en | |
| dc.publisher | جامعة الموصل /University of Mosul | |
| dc.relation.ispartofseries | 258R | |
| dc.subject | COVID-19 | |
| dc.subject | AstraZeneca | |
| dc.subject | Pfizer | |
| dc.subject | Sinopharm | |
| dc.subject | post-vaccine symptoms | |
| dc.subject | health care workers | |
| dc.title | Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study | |
| dc.type | Other |